Quality & Innovation Award at HNC 2026.
PharmaLinea was awarded the Leading Enterprise for Quality & Tech Breakthrough Award at HNC Shanghai 2026, one of the key nutraceutical events in Asia.
HNC Shanghai.
HNC Shanghai brings together leading players across the nutraceutical products space, including manufacturers, brands, and ingredient suppliers. The event serves as a platform for showcasing innovation, exchanging insights, and recognizing companies contributing to the advancement of quality and technology in the industry.
The Leading Enterprise for Quality & Tech Breakthrough Award was introduced in 2026, with its first edition recognizing companies demonstrating a strong commitment to quality, alongside continuous progress in technological development and product excellence.
PharmaLinea selected as the winner.
As a private label supplement manufacturer, PharmaLinea maintains a consistent focus on quality and innovation across its development and manufacturing processes. This award reflects that ongoing focus and approach.
The award also builds on PharmaLinea’s continued work in developing science-backed, market-ready nutraceutical products for partners globally.
“This recognition reflects the work and dedication of the team, whose consistent focus on execution and quality standards continues to support the company’s progress,” commented Anton Oražem, PharmaLinea’s CEO.
further reading.
reach out.
"*" indicates required fields
Oops! We could not locate your form.
"*" indicates required fields
WHY OUR PRODUCTS
By Indication
